Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kyung Nam Pharm HealthCare Co.,Ltd. (223310:KRX), powered by AI.
Kyung Nam Pharm HealthCare Co.,Ltd. is currently trading at ₩1,992. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kyung Nam Pharm HealthCare Co.,Ltd. on Alpha Lenz.
Kyung Nam Pharm HealthCare Co.,Ltd.'s P/E ratio is -4.0.
“Kyung Nam Pharm HealthCare Co.,Ltd. trades at a P/E of -4.0 (undervalued) with modest ROE of -47.6%.”
Ask for details →Deep Mind Platform Co., Ltd. is a notable entity in the technology sector, primarily focused on the development and implementation of cutting-edge artificial intelligence and machine learning solutions. The company specializes in creating platforms that leverage data analytics, natural language processing, and computer vision to revolutionize how industries operate across various domains. Deep Mind Platform Co., Ltd. plays a critical role in sectors such as healthcare, finance, and autonomous vehicles, providing tools that enhance efficiency, decision-making, and innovation. Its technology is pivotal in driving forward advancements in AI, helping businesses to optimize operations and improve customer experiences. As a key player in the tech industry, the company contributes significantly to the growing importance of AI technologies within the global market, influencing trends and shaping the future of intelligent automation. Founded with a vision to pioneer AI-driven solutions, Deep Mind Platform Co., Ltd. continues to expand its footprint, partnering with companies and institutions to harness the full potential of AI technologies.
“Kyung Nam Pharm HealthCare Co.,Ltd. trades at a P/E of -4.0 (undervalued) with modest ROE of -47.6%.”
Ask for details →Kyung Nam Pharm HealthCare Co.,Ltd. (ticker: 223310) is a company listed on KRX in the Unknown sector (Unknown). Market cap is $50.7B.
The current price is ₩1,992 with a P/E ratio of -3.99x and P/B of 1.96x.
ROE is -47.63% and operating margin is -14.80%. Annual revenue is $21.7B.